Bococizumab (Anti-PCSK9)
Product Specifications
CAS Number
1407495-02-6
Synonyms
PF-04950615; RN316
Target
PCSK9
Applications
Metabolism
Additionnal Information
Bococizumab (Anti-PCSK9) is a humanized monoclonal IgG2Δa antibody against proprotein convertase subtilisin/kexin type 9 (PCSK9) used for the treatment of hyperlipidemia. MW: 145.06 kD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
